September 01, 2021

Looking Ahead to Factors Shaping Market Activity

A bylined article exploring the factors shaping M&A activity in the life sciences sector by EMEA CRO Merlin Piscitelli was published in the September issue of Pharmaceutical Technology Europe. The article highlights how the sector continues to attract investor interest despite unprecedented disruption caused by the pandemic. 

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

Senior Vice President, Finance & Treasury

651.632.4009

[email protected]

You may also like:

Global M&A Deal Numbers Up 3% in 2022

Datasite's Forecaster report shows that deal activity is up 3% year-over-year through October.

6 Ways to Help Your Employees Get the Holiday Break They Need

CHRO Deb LaMere discusses the importance of employee rest and recharge over the holidays.

SHRM Logo
DealTech: M&A activity holds firm despite macro conditions – VDR Insight

M&A activity is likely to remain stable in 1H23 despite a tough macro-economic environment, according to providers of virtual data rooms (VDRs).